Dewey McLin

Computer Sciences Corp. provided information technology solutions. It operated through the global business services, global infrastructure services segments. The company was founded by Roy Nutt and Fletcher Roseberry Jones on April 16, 1959 and was headquartered in Tysons, VA.

Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY.

Part of Nanomune Technologies, Inc., Aspira Biosystems, Inc. develops technology that enables the capture of targeted proteins. The company is based in San Francisco, CA. The company was founded by Casey Crawford Lynch. Aspira Biosystems was acquired by Nanomune Technologies, Inc. on July 20, 2004.

Axon Capital LP is a registered investment advisor and hedge fund manager headquartered in New York City. Formerly known as TPG-Axon Management LP, the firm is a successor to Axon Investments LP, its parent company, which was founded by Dinakar Singh in February 2005. Axon Capital provides discretionary investment advisory services to domestic and offshore private investment vehicles.

The Drug Information Association is a non-profit multidisciplinary association that operates to promote health and well-being. The non-profit company is based in Horsham, PA. Marwan Fathallah has been the CEO of the company since 2023.

The State Bar of Georgia is an organization that provides resources and support for lawyers in the state of Georgia. The organization is based in Atlanta, GA and offers programs such as committees, sections, and a lawyer assistance program. The private company's website offers a variety of services, including a member directory, legal aid resources, and virtual law museum. Additionally, they offer a comprehensive law library called Fastcase, which is a free member benefit for lawyers. The State Bar of Georgia also recommends Member Benefits, Inc. as a broker for members' health, dental, and vision insurance, as well as other approved products.

Pearl Therapeutics, Inc. develops therapies for the treatment of chronic respiratory diseases. It offers respiratory product development, high quality therapies for COPD, Asthma and treatment and prevention of chronic respiratory diseases and asthma. The company was founded in 2006 by Sarvajna Dwivedi and is headquartered in Redwood City, CA.

The Alzheimer's Drug Discovery Foundation (ADDF) is a public charity founded in 1998 by Ronald Steven Lauder, Leonard Alan Lauder, and Howard Fillit. The non-profit company is based in New York, NY. The ADDF is dedicated to accelerating the discovery of drugs to prevent, treat, and cure Alzheimer's disease. The company is the only public charity solely focused on funding the development of drugs for Alzheimer's, using a venture philanthropy model to support research in academia and the biotech industry. The ADDF has awarded over $209 million to fund over 690 Alzheimer's drug discovery programs, biomarker programs, and clinical trials in 19 countries. The CEO is Mark Roithmayr.

Neuroinsights LLC provides consultation and advice on investing in the neurotech industry. The company was founded by Casey and Zach Lynch and is headquartered in San Francisco, CA.

Pharmaco LSR, Inc. provides clinical research services.

Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE.

Tarrant Capital IP LLC operates as a venture capital firm. It serves the consumer, retail, technology, internet, healthcare, energy, cleantech, digital media, real estate, renewables and transportation industries. The company was founded by David Bonderman and Jim Coulter in 1992 and is headquartered in San Francisco, CA.

MicroPort Orthopedics, Inc. provides medical devices. It specializes in design, manufacture and marketing of reconstructive joint devices and related services. The company is headquartered in Arlington, TN.

Alopexx Enterprises LLC engages in investing and managing health care companies. It develops medical therapies and devices for infectious diseases, oncology, central nervous system, and orphan diseases. The firm commercializes an alternative for the treatment and prevention of staphylococcal and other bacterial infections and animal vaccines. The company was founded by Daniel R. Vlock, Deborah Ramsdell and Christine de los Reyes in 2011 and is headquartered in Concord, MA.

TPG Special Situations Partners LLC provides financial services. The company is headquartered in Fort Worth, TX.

California Life Sciences Association (CLSA) is the largest and most influential life sciences advocacy and business leadership organization in California. The non-profit company is based in South San Francisco, CA, and has offices in other locations as well. The company works closely with industry, government, academia, and others to shape public policy, improve access to innovative technologies, and grow California's life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors, and service providers throughout the state. Mike Guerra has been the CEO of the company since 2019.

Accelerating Therapeutics for Opportunities in Medicine (ATOM) is an American company that focuses on molecular design and modeling programs. The private company works with open-source software and AMPL packages to build models and analyze data. The company collaborates with Lawrence Livermore National Laboratory scientists to fight against COVID-19 by combining artificial intelligence/machine learning, bioinformatics, and supercomputing to help discover drugs. ATOM shares updates about their new partners, technical team members, and presentations on their website.

Aerium Therapeutics, Inc. is an American biotechnology company that focuses on epidemic and pandemic preparedness. The company is based in Lausanne and has operations in the United States. The company's mission is to discover and develop antibodies and small molecule antivirals against SARS-CoV-2 and other epidemic and pandemic threats. Aerium Therapeutics has a team of world-class scientists and biotechnology veterans, as well as experienced investors. Aerium's lead assets are monoclonal antibodies that show broad activity against important variants of concern (VOCs) of SARS-CoV-2, including Omicron and its subvariants. The company plans to expand its pipeline to antiviral therapeutics in late 2022 and will broaden its focus to other epidemic and pandemic threats in the future. The CEO of the company is Rajeev Venkayya.

Lighthouse Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company that specializes in precision medicine approaches to address major unmet medical needs. The private company is based in San Francisco, CA. The company's expertise lies in small molecule protease inhibition. Lighthouse's lead program, LHP588, is a phase 2b ready orally bioavailable small molecule that targets a specific infectious pathogen, Porphyromonas gingivalis. This pathogen is associated with chronic degenerative and inflammatory disorders such as dementia, periodontal disease, atherosclerosis, and orodigestive cancers. Lighthouse Pharmaceuticals was founded in 2022 by Casey Crawford Lynch, who has been the CEO since 2022.